SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Lai

(Last)

(First)

(Middle)

C/O MOURANT GOVERNANCE SERVICES (CAYMAN)

94 SOLARIS AVENUE

(Street)

CAMANA BAY, GRAND CAYMAN

KY1-1108

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2021

3. Issuer Name and Ticker or Trading Symbol
BeiGene, Ltd. [ BGNE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Global Head of R&D

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares⁽¹⁾	203,983	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share Option (Right to Buy)	⁽²⁾	07/13/2026	Ordinary Shares	233,948⁽³⁾	$2.29	D
Share Option (Right to Buy)	⁽⁴⁾	06/26/2027	Ordinary Shares	999,999⁽³⁾	$3.49	D
Share Option (Right to Buy)	⁽⁵⁾	06/25/2028	Ordinary Shares	364,208⁽³⁾	$12.34	D
Share Option (Right to Buy)	⁽⁶⁾	06/04/2029	Ordinary Shares	558,285⁽³⁾	$9.23	D
Share Option (Right to Buy)	⁽⁷⁾	06/16/2030	Ordinary Shares	525,564⁽³⁾	$13.42	D

Explanation of Responses:

1. Includes 176,241 shares underlying unvested restricted share units.

2. Fully vested on July 31, 2020.

3. The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

4. These securities vest over a four-year period as follows: 25% on June 27, 2018 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

5. These securities vest over a four-year period as follows: 25% on June 26, 2019 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

6. These securities vest over a four-year period as follows: 25% on June 5, 2020 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

7. These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Qing Nian, as Attorney-in-Fact	04/09/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.